RxDoctor Payments DataLook up a doctor →

Howard Lafferty, DO

Family Medicine · South Charleston, WVNPI 1508066648

Payments from drug & device makers

$8,313in general payments, 2019–2025

Across 530 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$872
  • Amgen$681
  • AstraZeneca$581
  • GSK$578
  • Pfizer$421
  • plus $4K from 34 others

What the payments were for

  • Food & beverage$8,21999%
  • Education$941%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,313 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$82,417
Medicare patients
382
Services billed
1,063

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$122,075
OzempicSemaglutide60$98,050
EliquisApixaban47$52,917
XareltoRivaroxaban39$41,926
FanaptIloperidone11$36,448
MounjaroTirzepatide31$34,011
Repatha SureclickEvolocumab44$29,205
FarxigaDapagliflozin Propanediol30$25,493
JanuviaSitagliptin Phosphate12$16,501
BrilintaTicagrelor31$13,732
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$12,669
MyrbetriqMirabegron11$12,586
LinzessLinaclotide14$10,862
Praluent PenAlirocumab12$10,849
SavellaMilnacipran Hcl14$10,773

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$348$122,07595 claims
Novo NordiskOzempic$1,153$98,05060 claims
PfizerEliquis$421$52,91747 claims
Johnson & JohnsonXarelto$362$41,92639 claims
AstraZenecaFarxiga, Brilinta$581$39,22561 claims
Lilly USA, LLCMounjaro$421$34,01131 claims
AbbVieLinzess, Savella, Synthroid$872$24,95864 claims
MerckJanuvia$43$16,50112 claims
GSKTrelegy Ellipta$578$12,66913 claims
Astellas Pharma US IncMyrbetriq$246$12,58611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.

Other family medicine in South Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →